Cambridge Investment Research Advisors’s SkinHealth Systems SKIN Stock Holding History

Cambridge Investment Research Advisors’s Portfolio SKIN Stock Details SKIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-13,833	Closed	-$43K	–	3395
2023 Q4	$43K	Hold	13,833	–	–	﹤0.01%	3109
2023 Q3	$83K	Sell	13,833 -9,919	-42%	-$69.7K	﹤0.01%	2987
2023 Q2	$199K	Sell	23,752 -100	-0.4%	-$1.04K	﹤0.01%	2877
2023 Q1	$301K	Sell	23,852 -1,270	-5%	-$14.7K	﹤0.01%	2488
2022 Q4	$229K	Buy	25,122 +100	+0.4%	+$1.08K	﹤0.01%	2648
2022 Q3	$295K	Hold	25,022	–	–	﹤0.01%	2375
2022 Q2	$322K	Sell	25,022 -1,080	-4%	-$14.5K	﹤0.01%	2319
2022 Q1	$441K	Buy	26,102 +14,323	+122%	+$236K	﹤0.01%	2212
2021 Q4	$285K	Sell	11,779 -762	-6%	-$19.6K	﹤0.01%	2569
2021 Q3	$326K	Buy	+12,541	New	+$276K	﹤0.01%	2392

Other funds holding SKIN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

LCG

Luxor Capital Group New York $1.43B AUM 30.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cambridge Investment Research Advisors's SKIN Position: Q1 2024 in Review

Cambridge Investment Research Advisors sold out of SkinHealth Systems (SKIN) in Q1 2024, closing a stake of 13,833 shares — an estimated $43K sold.

Cambridge Investment Research Advisors first reported a position in SKIN in Q3 2021 and held it in 10 quarters. The position peaked at $441K in Q1 2022. 120 funds tracked by Wall St. Rank hold SKIN as of Q1 2024.

Cambridge Investment Research Advisors reported no remaining SkinHealth Systems position as of Q1 2024 after selling out during the quarter.
Cambridge Investment Research Advisors sold 13,833 SkinHealth Systems shares in Q1 2024, an estimated $43K.
Cambridge Investment Research Advisors first reported a position in SkinHealth Systems in Q3 2021 and held it in 10 quarters.
Cambridge Investment Research Advisors's SkinHealth Systems position peaked at $441K in Q1 2022.
120 funds tracked by Wall St. Rank held SkinHealth Systems as of Q1 2024.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2024, filed 24 Apr 2024.